Author： LeVine Steven M Bilgen Mehmet Lynch Sharon G
Publisher： Informa Healthcare
ISSN： 1473-7175
Source： Expert Review of Neurotherapeutics, Vol.13, Iss.3, 2013-03, pp. : 247-250
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pharmacological Treatment of Early Multiple Sclerosis
By Stüve Olaf Bennett Jeffrey L. Hemmer Bernhard
Drugs, Vol. 68, Iss. 1, 2008-01 ,pp. :
Access to resources
Recommend
Natalizumab: Early multiple sclerosis relapse: 7 case reports
Reactions Weekly, Vol. 1, Iss. 1222, 2008-01 ,pp. :
Interferon-β-1b of benefit in early multiple sclerosis
Inpharma, Vol. 1, Iss. 1512, 2005-01 ,pp. :
Early-Stage Multiple Sclerosis: What Are the Treatment Options?
Drugs, Vol. 64, Iss. 18, 2004-01 ,pp. :
Natalizumab: multiple benefits in multiple sclerosis
Inpharma, Vol. 1, Iss. 1487, 2005-01 ,pp. :